Researchers take a fresh look at hallucinogens

For decades the study of the therapeutic potential of hallucinogens had been badly discredited by the outsized claims made by researchers back in the 1960s. But new research has highlighted the potential therapeutic value of hallucinogens like the mushroom psilocybin for treating depression in cancer victims, post-traumatic stress disorder, obsessive-compulsive disorder, addiction, end-of-life stress and more. Subjects have described intense spiritual experiences similar to religious mystics. Article

Suggested Articles

The analysis found Nexvax2 was no better than placebo at protecting patients from gluten, prompting the Arch-backed biotech to stop the study.

Johns Hopkins scientists found that misfolded alpha-synuclein protein can travel from the gut and drive Parkinson's disease.

The financing sets Sanifit up to take its lead drug through phase 3 while exploring its potential in other progressive vascular calcification disorders.